Flagship Journal - European Medical Journal

This site is intended for healthcare professionals

Continue

Flagship Journal

Filter
EMJ 6.3 2021 Feature Image
9 Mins
21 Sep 2021

Embedding State-of-the-Art of Cardiac Fibrosis Imaging into Standard Practice

The 12-lead ECG has long played the leading role in identifying the region of the heart responsible for tachycardia…
EMJ 6.3 2021 Feature Image
6 Mins
21 Sep 2021

Perspectives of the Methofill® (Methotrexate) Pre-filled Injector Device: Insights from a Rheumatology Nurse Consultant and Results from a Real Life Patient Experience Survey

Rheumatoid arthritis (RA) is a chronic, progressive, inflammatory joint disease characterised by symmetrical inflammation of the peripheral…
EMJ 6.3 2021 Feature Image
10 Mins
21 Sep 2021

Editor's Pick: The Role of Confocal Endomicroscopy in the Diagnosis and Management of Pancreatic Cysts

Pancreatic cystic lesions (PCLs) are an increasingly common finding. They are present in 1.2–2.6% of patients undergoing abdominal…
EMJ 6.3 2021 Feature Image
12 Mins
21 Sep 2021

Using Innovation to Develop Digital Tools for Public Health During the COVID-19 Pandemic

This paper describes a case study of the co-design and development of two new COVID-19 digital services to support the Scottish…
EMJ 6.3 2021 Feature Image
8 Mins
21 Sep 2021

Liver Transplantation in Patients with Acute-on-Chronic Liver Failure: Challenging the Limits

The natural history of patients with cirrhosis is characterised by the development of acute decompensating events…
EMJ 6.3 2021 Feature Image
14 Mins
21 Sep 2021

Portal Hypertension in Non-alcoholic Fatty Liver Disease in the Era of Non-invasive Assessment

Non-alcoholic fatty liver disease (NAFLD) is considered as one of the fastest emerging global health priorities due to the continuous…
EMJ 6.3 2021 Feature Image
6 Mins
21 Sep 2021

Review of Rifaximin: A Summary of the Current Evidence and Benefits Beyond Licensed Use

The benefits of rifaximin use continues to gather momentum, given its well-tolerated side-effect profile, and these require consideration.
EMJ 6.3 2021 Feature Image
10 Mins
21 Sep 2021

Which Biologic Therapies to Treat Active Rheumatoid Arthritis and When?

The arrival of biologic disease-modifying anti-arthritis drugs (bDMARD) has vastly improved the outcomes of patients
We’ve noticed you’re accessing
from North/South America.